Contrast-induced nephropathy in a patient with type 2 diabetes and coronary artery disease: a case report

J Int Med Res. 2021 Aug;49(8):3000605211033177. doi: 10.1177/03000605211033177.

Abstract

Contrast-induced nephropathy (CIN) is the impairment of kidney function defined as a serum creatinine increase of 25% or 44 µmol/L compared with baseline, usually occurring 24 to 48 hours after the use of intravenous contrast. Important risk factors for CIN include female sex, advanced age (>65 years), type 2 diabetes (T2D), kidney disease, advanced heart failure, and intravascular volume depletion. We herein present a male patient with T2D, moderately reduced renal function, no albuminuria, and a positive echocardiography stress test. He underwent percutaneous coronary intervention (PCI), and two drug-eluting stents (in the left anterior descending coronary artery) and three bare-metal stents (in the right coronary artery) were implanted. Despite adequate rehydration (0.9% intravenous NaCl with 8.4% sodium bicarbonate) before and after the procedures, he developed irreversible kidney injury after coronary angiography and PCI. This case report demonstrates the unpredictable clinical course of CIN. Patients with T2D are at high risk for the occurrence of CIN, so careful clinical assessment is recommended with global renal functional reserve evaluation.

Keywords: Contrast-induced nephropathy; acute kidney injury; coronary artery disease; iso-osmolar contrast media; percutaneous coronary intervention; type 2 diabetes.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Contrast Media / adverse effects
  • Coronary Angiography
  • Coronary Artery Disease* / complications
  • Coronary Artery Disease* / diagnostic imaging
  • Creatinine
  • Diabetes Mellitus, Type 2* / complications
  • Diabetes Mellitus, Type 2* / drug therapy
  • Female
  • Humans
  • Kidney Diseases*
  • Male
  • Percutaneous Coronary Intervention*
  • Retrospective Studies
  • Risk Factors

Substances

  • Contrast Media
  • Creatinine